01
(−)-Alloaromadendrene
No data
- Entity Type
- Diseases
- Relation Groups
- 3
- Relation Preview
- 24
Basic Information
Grouped by core information, identifiers, and descriptions.
Current candidates are inferred from disease-target-ingredient-herb paths and do not represent a formal recommendation ranking.
Core Information
- Disease Name
- Dyskinetic Syndrome
- Standard Disease Name
- dyskinetic syndrome
- MeSH Tree
- No data
- ICD-10
- G24.9
Identifiers
- DO ID
- No data
- MeSH ID
- D020820
- OMIM ID
- MTHU037456|MTHU039441
- UMLS ID
- C0013384
- HPO ID
- No data
Description and Extensions
- Description
- PSY2004:Abnormal involuntary motor processes that occur due to underlying disease processes.|NCI2016_NICHD_1602D:Impairment of voluntary muscle control, characterized by spasmodic or repetitive motions or lack of coordination.|NCI2016_FDA_1602D:Difficulty moving; distortion or impairment of voluntary movement, as in tic, spasm, or myoclonus.|NCI2016_02D:Abnormality or impairment of voluntary movement.|MSH2017_2016_08_12:Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.|HPO2016_07_04:A movement disorder which consists of effects including diminished voluntary movements and the presence of involuntary movements. [HPO:sdoelken]|CHV2011_02:a disease characterized by abnormal involuntary movements of muscles
Related
Related Entities
Direct relations and traceable candidates grouped by relation type.
Candidate Ingredients
target disease -> ingredient target8 Ingredients
02
()-Cuparene
No data
03
()-N-Methylephedrine
No data
04
()-N-Methylpseudoephedrine
No data
05
06
07
(+)-Anwulignan
No data
08